[1]
Baena Cañada, J.M. et al. 2021. Trends in Adjuvant Chemotherapy Use in Endocrine-Sensitive, HER-2 Negative Breast Cancer, With 1 to 3 Positive Nodes: A Single-Centre Study. Archives of Breast Cancer. (Jul. 2021), 233–242. DOI:https://doi.org/10.32768/abc.202183233-242.